Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
We have all seen the never-ending stream of global headlines predicting the demise of western health care as we know it. This includes overburdened health care professionals (HCPs), declines in enrollment in academic health disciplines, insufficient physical resources and infrastructure, drug shortages, rising costs, and increasing demand.
Perhaps it is time to shine a light on one of the most underleveraged and oft-overlooked disciplines in the HCP armamentarium, namely, pharmacists. Not surprisingly, pharmacists continue to have a significant impact on their patient populations, according to data presented in a recent article.1
Although this may be new to the general population, the pharma-health industry always knew this unspoken truth. The study data were collected in British Columbia (BC), Canada, in which, “pharmacists recently gained the ability to administer more vaccines and renew or adjust prescriptions for a wider range of drugs…” This change began in October 2022.
The types of potential modifications they now have control over include changes to:1
Recent BC government data showed nearly 60,000 prescriptions were renewed or modified by pharmacists in January 2023, which is more than double the monthly average of approximately 27,200 in the year before the changes. These data indicate a 120% increase in the number of residents renewing or adjusting prescriptions, via their pharmacists, after their powers changed.
This scenario is quite useful in helping health strategy and marketing professionals qualify and quantify the everyday influence pharmacists have with their patients. Although not a controlled study per se, there is a clear in-market “before and after” timeframe and the date of the change in prescribing abilities is exactly known.
Further, the types of changes are clearly identifiable, and the number of renewed/modified prescriptions is from government sources. In summary, the data appear stable, providing firm ground from which to draw a variety of business and marketing observations and insights on the critical importance of pharmacists in the delivery of successful treatment.
As context, across the HCP ecosystem, there are numerous individuals involved in therapeutic outcomes, but the new study data confirm pharmacists are in a truly pivotal role. In some instances, pharmacists, likely by virtue of their (retail) accessibility, are seen by patients more frequently than any other HCP.2
Also, pharmacists have never been as well educated as they are today. Most graduates over the past 10-plus years have earned a PharmD and those who have been in the industry longer remain among the highest trained as RPh-degreed professionals.
Further, in independent studies, pharmacists are consistently ranked as highly trusted HCPs just behind physicians and nurses,3 thus their recognition as a prescribing and support entity in the health ecosystem continues to grow. The best way to embrace their functionality is to consider a few typical health scenarios and the presented professional communications opportunity for pharmacists:
Insight: For Rx brands distributed through retail, the relative importance of pharmacists (compared to physicians) has been underestimated and under-attributed.
Insight: With new approaches to designing and delivering medical education, investing in pharmacists should yield a high return.
Insight: As a subset of HCPs, their specialty drives efficiencies in channel mix and effectiveness in messaging. Audience reach, frequency, and most importantly, composition, are attainable and may even be done in cooperation with the retail chains themselves, all of which improve the efficacy of pharmacist communication.
Insight: With hands-on involvement at the transaction level, pharmacists are literally on the frontline of Rx starts (NBRx and NRx), ongoing (adherent) therapy, and drivers of market share and financial impact.
The data that came out of the BC scenario is a tantalizing snippet of the potential value of the pharmacist audience. It also triggers a variety of Rx brand strategy questions.
For example, can value be assigned and is there a way to develop more solid analytics that will validate the importance of pharmacists within Rx attribution models? What are the most impactful channels with which to reach pharmacists? Is there an opportunity to design and deliver medical education specifically for the pharmacist?
While all health care professionals are key players in treatment, pharmacists are and always will be critically important in care delivery and the opportunity is to leverage their patient access and frontline insights to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
About the Authors
Kent Groves, PhD; chief strategy officer, Dentsu Health
Jeff Godish, principal, Delta Strada
Croom Lawrence, principal, Predictive Healthcare
1. Globe and Mail, May 18, 2023. BC reports 120% increase in prescriptions after pharmacists gain new powers.
2. Most patients see pharmacists as crucial part of their health care team. American Pharmacists Association. News release. January 21, 2022. www.pharmacist.com/APhA-Press-Releases/most-patients-see-pharmacists-as-crucial-part-of-their-health-care-team
3. Brenan, M. Nurses Retain Top Ethics Rating in U.S., but Below 2020 High. Gallup. January 10, 2023. news.gallup.com/poll/467804/nurses-retain-top-ethics-rating-below-2020-high.aspx